Ann: Quarterly Results and Investor Conference Call Notification, page-30

@theoc , with a PCR test costing well over $100 and a RAT costing north of $10 I think you should revisit your revenue estimates using $1 per test.

Fair price for a takeover now is an incredibly difficult question to answer, and every individual will have a different numbers. Before the takeover I was hoping the share price would be between 15c and 20c by the end of this calendar year, approaching 50c by the end of CY2023 and approaching $1 plus a dividend by the end of CY2024. What would that be worth to me if you offered me cash in mid June... ¯\_(ツ)_/¯ ...

But of course all this was before the Covid19 result. Now all bets are off and no offer is likely to be acceptable. I need to see commercial results and some track record before deciding on a number.